vs
藏寿司（KRUS）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是藏寿司的1.0倍（$75.5M vs $73.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 14.0%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $-13.3M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 13.2%）
藏寿司是日本知名回转寿司连锁品牌，为日本第二大寿司连锁企业，规模仅次于寿司郎，领先滨寿司。品牌总部设于大阪府堺市，目前在日本拥有543家门店，在中国台湾地区开设56家门店，另在美国布局有69家门店。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
KRUS vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.0倍
$73.5M
营收增速更快
PBYI
高出13.8%
14.0%
自由现金流更多
PBYI
多$27.7M
$-13.3M
两年增速更快
PBYI
近两年复合增速
13.2%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $73.5M | $75.5M |
| 净利润 | $-3.1M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | -5.0% | 22.7% |
| 净利率 | -4.2% | — |
| 营收同比 | 14.0% | 27.7% |
| 净利润同比 | -218.4% | — |
| 每股收益（稀释后） | $-0.25 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KRUSPBYI
| Q4 25 | $73.5M | $75.5M | ||
| Q3 25 | $79.4M | $54.5M | ||
| Q2 25 | $74.0M | $52.4M | ||
| Q1 25 | $64.9M | $46.0M | ||
| Q4 24 | $64.5M | $59.1M | ||
| Q3 24 | $66.0M | $80.5M | ||
| Q2 24 | $63.1M | $47.1M | ||
| Q1 24 | $57.3M | $43.8M |
净利润KRUSPBYI
| Q4 25 | $-3.1M | — | ||
| Q3 25 | $2.3M | $8.8M | ||
| Q2 25 | $565.0K | $5.9M | ||
| Q1 25 | $-3.8M | $3.0M | ||
| Q4 24 | $-961.0K | — | ||
| Q3 24 | $-5.2M | $20.3M | ||
| Q2 24 | $-558.0K | $-4.5M | ||
| Q1 24 | $-998.0K | $-4.8M |
毛利率KRUSPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率KRUSPBYI
| Q4 25 | -5.0% | 22.7% | ||
| Q3 25 | 1.8% | 17.6% | ||
| Q2 25 | -0.2% | 12.7% | ||
| Q1 25 | -7.1% | 8.7% | ||
| Q4 24 | -2.3% | 22.6% | ||
| Q3 24 | -8.8% | 27.4% | ||
| Q2 24 | -1.9% | -4.6% | ||
| Q1 24 | -2.9% | -5.3% |
净利率KRUSPBYI
| Q4 25 | -4.2% | — | ||
| Q3 25 | 2.9% | 16.2% | ||
| Q2 25 | 0.8% | 11.2% | ||
| Q1 25 | -5.8% | 6.5% | ||
| Q4 24 | -1.5% | — | ||
| Q3 24 | -7.9% | 25.2% | ||
| Q2 24 | -0.9% | -9.6% | ||
| Q1 24 | -1.7% | -11.0% |
每股收益（稀释后）KRUSPBYI
| Q4 25 | $-0.25 | $0.26 | ||
| Q3 25 | $0.18 | $0.17 | ||
| Q2 25 | $0.05 | $0.12 | ||
| Q1 25 | $-0.31 | $0.06 | ||
| Q4 24 | $-0.08 | $0.40 | ||
| Q3 24 | $-0.47 | $0.41 | ||
| Q2 24 | $-0.05 | $-0.09 | ||
| Q1 24 | $-0.09 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $50.7M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $229.2M | $130.3M |
| 总资产 | $443.5M | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资KRUSPBYI
| Q4 25 | $50.7M | $97.5M | ||
| Q3 25 | $62.5M | $94.4M | ||
| Q2 25 | $60.5M | $96.0M | ||
| Q1 25 | $85.2M | $93.2M | ||
| Q4 24 | $107.7M | $101.0M | ||
| Q3 24 | $51.0M | $96.7M | ||
| Q2 24 | $60.7M | $96.8M | ||
| Q1 24 | $62.8M | $107.2M |
总债务KRUSPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益KRUSPBYI
| Q4 25 | $229.2M | $130.3M | ||
| Q3 25 | $231.1M | $115.3M | ||
| Q2 25 | $227.0M | $104.7M | ||
| Q1 25 | $225.0M | $97.1M | ||
| Q4 24 | $227.6M | $92.1M | ||
| Q3 24 | $162.5M | $71.1M | ||
| Q2 24 | $166.4M | $48.5M | ||
| Q1 24 | $165.3M | $51.0M |
总资产KRUSPBYI
| Q4 25 | $443.5M | $216.3M | ||
| Q3 25 | $430.9M | $202.9M | ||
| Q2 25 | $419.4M | $194.9M | ||
| Q1 25 | $410.4M | $196.2M | ||
| Q4 24 | $403.8M | $213.3M | ||
| Q3 24 | $328.5M | $220.7M | ||
| Q2 24 | $324.7M | $205.0M | ||
| Q1 24 | $315.5M | $214.1M |
负债/权益比KRUSPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $529.0K | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $-13.3M | $14.4M |
| 自由现金流率自由现金流/营收 | -18.1% | 19.1% |
| 资本支出强度资本支出/营收 | 18.8% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-27.5M | $41.7M |
8季度趋势，按日历期对齐
经营现金流KRUSPBYI
| Q4 25 | $529.0K | $14.4M | ||
| Q3 25 | $9.4M | $9.7M | ||
| Q2 25 | $6.7M | $14.1M | ||
| Q1 25 | $4.3M | $3.6M | ||
| Q4 24 | $4.4M | $15.6M | ||
| Q3 24 | $669.0K | $11.0M | ||
| Q2 24 | $8.7M | $1.0M | ||
| Q1 24 | $3.8M | $11.2M |
自由现金流KRUSPBYI
| Q4 25 | $-13.3M | $14.4M | ||
| Q3 25 | $-79.0K | $9.7M | ||
| Q2 25 | $-6.9M | $14.1M | ||
| Q1 25 | $-7.3M | $3.6M | ||
| Q4 24 | $-7.2M | $15.6M | ||
| Q3 24 | $-9.6M | $11.0M | ||
| Q2 24 | $-2.4M | $1.0M | ||
| Q1 24 | $-9.7M | — |
自由现金流率KRUSPBYI
| Q4 25 | -18.1% | 19.1% | ||
| Q3 25 | -0.1% | 17.7% | ||
| Q2 25 | -9.3% | 26.8% | ||
| Q1 25 | -11.2% | 7.7% | ||
| Q4 24 | -11.2% | 26.4% | ||
| Q3 24 | -14.6% | 13.7% | ||
| Q2 24 | -3.8% | 2.1% | ||
| Q1 24 | -16.9% | — |
资本支出强度KRUSPBYI
| Q4 25 | 18.8% | 0.0% | ||
| Q3 25 | 11.9% | 0.0% | ||
| Q2 25 | 18.4% | 0.0% | ||
| Q1 25 | 17.8% | 0.1% | ||
| Q4 24 | 17.9% | 0.0% | ||
| Q3 24 | 15.6% | 0.0% | ||
| Q2 24 | 17.6% | 0.0% | ||
| Q1 24 | 23.5% | 0.0% |
现金转化率KRUSPBYI
| Q4 25 | — | — | ||
| Q3 25 | 4.12× | 1.10× | ||
| Q2 25 | 11.88× | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
